Karine Pallier

1.1k total citations
11 papers, 880 citations indexed

About

Karine Pallier is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Karine Pallier has authored 11 papers receiving a total of 880 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Karine Pallier's work include Lung Cancer Treatments and Mutations (5 papers), Cancer Genomics and Diagnostics (4 papers) and RNA modifications and cancer (3 papers). Karine Pallier is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Cancer Genomics and Diagnostics (4 papers) and RNA modifications and cancer (3 papers). Karine Pallier collaborates with scholars based in France, Germany and United States. Karine Pallier's co-authors include Pierre Laurent‐Puig, Hélène Blons, Delphine Le Corre, Audrey Didelot, Léonor Benhaïm, Aurélie Cazes, Bruno Landi, Olivier Bouché, Steve K. Kotsopoulos and Deniz Pekin and has published in prestigious journals such as PLoS ONE, International Journal of Cancer and Clinical Chemistry.

In The Last Decade

Karine Pallier

11 papers receiving 870 citations

Peers

Karine Pallier
Neal Lindeman United States
Clarinda Chua Singapore
Marina Baretti United States
Soo Kyung Nam South Korea
Astrid J Bosma Netherlands
Leonie Voorwerk Netherlands
Karine Pallier
Citations per year, relative to Karine Pallier Karine Pallier (= 1×) peers Audrey Didelot

Countries citing papers authored by Karine Pallier

Since Specialization
Citations

This map shows the geographic impact of Karine Pallier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karine Pallier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karine Pallier more than expected).

Fields of papers citing papers by Karine Pallier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karine Pallier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karine Pallier. The network helps show where Karine Pallier may publish in the future.

Co-authorship network of co-authors of Karine Pallier

This figure shows the co-authorship network connecting the top 25 collaborators of Karine Pallier. A scholar is included among the top collaborators of Karine Pallier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karine Pallier. Karine Pallier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Legras, Antoine, Nicolas Pécuchet, Sandrine Imbeaud, et al.. (2017). Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung Cancer. Cancers. 9(8). 101–101. 65 indexed citations
2.
Pécuchet, Nicolas, Pierre Laurent‐Puig, Audrey Mansuet‐Lupo, et al.. (2015). Different prognostic impact ofSTK11mutations in non-squamous non-small-cell lung cancer. Oncotarget. 8(14). 23831–23840. 67 indexed citations
3.
Laforest, A., Thomas Aparicio, Aziz Zaanan, et al.. (2014). ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma. European Journal of Cancer. 50(10). 1740–1746. 72 indexed citations
4.
Taly, Valérie, Deniz Pekin, Léonor Benhaïm, et al.. (2013). Multiplex Picodroplet Digital PCR to Detect KRAS Mutations in Circulating DNA from the Plasma of Colorectal Cancer Patients. Clinical Chemistry. 59(12). 1722–1731. 380 indexed citations
5.
Manceau, Gilles, Éric Letouzé, Cécile Guichard, et al.. (2012). Recurrent inactivating mutations of ARID2 in non‐small cell lung carcinoma. International Journal of Cancer. 132(9). 2217–2221. 58 indexed citations
6.
Pallier, Karine, Anatole Cessot, Jean‐François Côté, et al.. (2012). TWIST1 a New Determinant of Epithelial to Mesenchymal Transition in EGFR Mutated Lung Adenocarcinoma. PLoS ONE. 7(1). e29954–e29954. 51 indexed citations
7.
Didelot, Audrey, Delphine Le Corre, Armelle Luscan, et al.. (2012). Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples. Experimental and Molecular Pathology. 92(3). 275–280. 91 indexed citations
8.
Pallier, Karine, Aurélie Cazes, Laïla El Khattabi, et al.. (2011). DeltaN TP63 reactivation, epithelial phenotype maintenance, and survival in lung squamous cell carcinoma. Tumor Biology. 33(1). 41–51. 4 indexed citations
9.
Just, Pierre‐Alexandre, Aurélie Cazes, Anne Audebourg, et al.. (2011). Histologic subtypes, immunohistochemistry, FISH or molecular screening for the accurate diagnosis of ALK-rearrangement in lung cancer: A comprehensive study of Caucasian non-smokers. Lung Cancer. 76(3). 309–315. 49 indexed citations
10.
Pallier, Karine, Anne‐Marie Houllier, Delphine Le Corre, et al.. (2009). No somatic genetic change in the paxillin gene in nonsmall‐cell lung cancer. Molecular Carcinogenesis. 48(7). 581–585. 12 indexed citations
11.
Blons, Hélène, Karine Pallier, Delphine Le Corre, et al.. (2008). Genome wide SNP comparative analysis between EGFR and KRAS mutated NSCLC and characterization of two models of oncogenic cooperation in non-small cell lung carcinoma. BMC Medical Genomics. 1(1). 25–25. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026